FR2899587B1 - Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee - Google Patents

Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee

Info

Publication number
FR2899587B1
FR2899587B1 FR0651268A FR0651268A FR2899587B1 FR 2899587 B1 FR2899587 B1 FR 2899587B1 FR 0651268 A FR0651268 A FR 0651268A FR 0651268 A FR0651268 A FR 0651268A FR 2899587 B1 FR2899587 B1 FR 2899587B1
Authority
FR
France
Prior art keywords
activator
lactose
regulator
derived
glycoside compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651268A
Other languages
English (en)
Other versions
FR2899587A1 (fr
Inventor
Nathalie Pineau
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0651268A priority Critical patent/FR2899587B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to CN2007800123866A priority patent/CN101553478B/zh
Priority to ES07727832.3T priority patent/ES2637508T3/es
Priority to EP07727832.3A priority patent/EP2010510B1/fr
Priority to US12/296,304 priority patent/US8217164B2/en
Priority to CN201210301871.8A priority patent/CN102871860B/zh
Priority to PCT/EP2007/053364 priority patent/WO2007116015A1/fr
Publication of FR2899587A1 publication Critical patent/FR2899587A1/fr
Application granted granted Critical
Publication of FR2899587B1 publication Critical patent/FR2899587B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0651268A 2006-04-07 2006-04-07 Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee Expired - Fee Related FR2899587B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0651268A FR2899587B1 (fr) 2006-04-07 2006-04-07 Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee
ES07727832.3T ES2637508T3 (es) 2006-04-07 2007-04-05 Uso de un compuesto de C-glucósido derivado de lactosa como agente para activar y regular la inmunidad cutánea
EP07727832.3A EP2010510B1 (fr) 2006-04-07 2007-04-05 Utilisation d'un composé c-glycoside dérivé du lactose en tant qu'agent pour activer et réguler l'immunité cutanée
US12/296,304 US8217164B2 (en) 2006-04-07 2007-04-05 Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity
CN2007800123866A CN101553478B (zh) 2006-04-07 2007-04-05 乳糖衍生的c-糖苷化合物作为用于活化和调节皮肤免疫性的试剂的应用
CN201210301871.8A CN102871860B (zh) 2006-04-07 2007-04-05 乳糖衍生的c-糖苷化合物作为用于活化和调节皮肤免疫性的试剂的应用
PCT/EP2007/053364 WO2007116015A1 (fr) 2006-04-07 2007-04-05 Utilisation d'un composé c-glycoside dérivé du lactose en tant qu'agent pour activer et réguler l'immunité cutanée

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651268A FR2899587B1 (fr) 2006-04-07 2006-04-07 Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee

Publications (2)

Publication Number Publication Date
FR2899587A1 FR2899587A1 (fr) 2007-10-12
FR2899587B1 true FR2899587B1 (fr) 2008-11-28

Family

ID=37054665

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651268A Expired - Fee Related FR2899587B1 (fr) 2006-04-07 2006-04-07 Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee

Country Status (3)

Country Link
CN (2) CN101553478B (fr)
ES (1) ES2637508T3 (fr)
FR (1) FR2899587B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750864B1 (fr) * 1996-07-10 1999-04-16 Oreal Utilisation d'un polyholoside dans une composition destinee a stimuler les defenses immunitaires, et composition le comprenant
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
CA2493690C (fr) * 2002-06-13 2011-11-08 New York University C-glycolipide de synthese et utilisation de celui-ci pour le traitement du cancer, des maladies infectieuses et des maladies auto-immunes
FR2882516B1 (fr) * 2005-02-25 2007-05-25 Oreal Utilisation capillaire des derives c-glycosides

Also Published As

Publication number Publication date
CN102871860A (zh) 2013-01-16
ES2637508T3 (es) 2017-10-13
CN101553478B (zh) 2012-10-10
FR2899587A1 (fr) 2007-10-12
CN102871860B (zh) 2015-09-16
CN101553478A (zh) 2009-10-07

Similar Documents

Publication Publication Date Title
HUS1800010I1 (hu) 4-Fenil-6-(2,2,2-trifluor-1-feniletoxi)pirimidin-alapú vegyületek és alkalmazási eljárásaik
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
FR2958542B1 (fr) Utilisation cosmetique de l'oridonine comme agent amincissant
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
FR2921259B1 (fr) Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
FR2899588B1 (fr) Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
ATE548019T1 (de) Hautaufhellende mittel, zusammensetzungen und verfahren
FR2899464B1 (fr) Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee
FR2891737B1 (fr) Utilisation de composes c-glycosides pour depigmenter la peau
FR2899468B1 (fr) Utilisation de c-glycosides derives de galactose comme agent protecteur et/ou activateur des lumphocytes gamma delta t
FR2899469B1 (fr) Utilisation de derive de d- et l-fucose comme agent protecteur et/ou activateur des lymphocytes gamma delta t
FR2899474B1 (fr) Utilisation de compose c-glycoside derive d- et l-fucose comme agent activateur et regulateur de l'imminite cutanee
FR2899466B1 (fr) Utilisation de compose c-glycoside agent activateur et regulateur de l'immunite cutanee
FR2899587B1 (fr) Utilisation de compose c-glycoside derive de lactose comme agent activateur et regulateur de l'immunite cutanee
HU0401422D0 (en) Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
FR2899463B1 (fr) Utilisation dej compose c-glycoside comme agent activateur et regulateur de l'immunite cutanee
FR2850578B1 (fr) Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
FR2864956B1 (fr) Compose derive de 1,3-diphenylprop-2-en-1-one, preparation et utilisations
FR2901793B1 (fr) Amides hydroxylees comme agents d'hydratation de la peau
GB2438975B (en) Hairdresser's masking aid
GB2433888B (en) Topical use of epoxidised compounds selected from vernolic acid and vernonia oil on skin
FR2889808B1 (fr) Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
FR2908650B1 (fr) Utilisation d'une alkyloxazolidinone comme agent cosmetique hydratant et procede d'hydratation de la peau.
FR2883172B1 (fr) Utilisation d'un tensioactif gemine comme agent anti-rides

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20211205